SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaint Gobain Or Regulatory News (COD)

  • There is currently no data for COD

Acquisition

29 Jul 2025 17:10

RNS Number : 0649T
Compagnie de Saint-Gobain
29 July 2025
 

SAINT-GOBAIN reinforcES ITS construction chemicals platform WITH three bolt-on ACQUISITIONsin North america, Italy and peru

 

 

Saint-Gobain reinforces its construction chemicals platform with:

 

· Two acquisitions securing key technologies that it will scale across the Group, Interstar Materials in North America and Isoltech in Italy;

 

· A local acquisition in Peru, Soquimic, enhancing Saint-Gobain's footprint in this high-growth market.

 

Interstar Materials is a leading North American manufacturer of high-performance pigments for all segments of concrete including ready-mix and precast concrete. Established in 1987, it operates two facilities in Canada (Quebec and Alberta) and one in the United States (Illinois). Concrete coloring has become popular amongst architects and contractors, with granular pigments having many advantages over liquid or powder pigments: they yield more vibrant colors, are simple to transport and store, easy to handle without temperature constraints and more environmentally friendly. Interstar will enrich Saint-Gobain's range of solutions for the growing demand in decorative concrete solutions for façade, flooring and architectural elements and benefit from the Group's strong presence in construction chemicals in North America.

 

Isoltech is an Italian manufacturer of additives specialized in cellular concrete technology used in the production of lightweight concrete. Established in 1987, it operates a production facility in Verdellino, northern Italy. Its solutions are widely recognized for their excellent thermal and acoustic insulation, as well as their fire resistance, recyclability, vapor and water permeability. Isoltech serves the ready-mix concrete, precast and screed markets.

 

Soquimic is a leading manufacturer of concrete admixtures in Peru. Established in 2013, the company has two plants located in Lurin, near Lima, and in Arequipa, in southern Peru. This transaction will enrich Saint-Gobain's range of solutions and accelerate its growth in Peru, following the acquisition of Z Aditivos in 2021, offering cement additives, and will complement the offering of Weber tile adhesives and facade renders.

 

Interstar, Isoltech and Soquimic generate revenues of around €25 million. They will benefit from Chryso's expertise, innovation and R&D capabilities to support customers in the development of low-carbon materials and from Saint-Gobain's global geographical footprint to expand their portfolio and value proposition in the market.

 

These acquisitions are in line with Saint-Gobain's strategic plan, "Grow & Impact" which aims to both strengthen the Group's worldwide leadership and accelerate its growth by enriching its range of solutions for light and sustainable construction.

 

About Saint-Gobain

Worldwide leader in light and sustainable construction, Saint-Gobain designs, manufactures and distributes materials and services for the construction and industrial markets. Its integrated solutions for the renovation of public and private buildings, light construction and the decarbonization of construction and industry are developed through a continuous innovation process and provide sustainability and performance. The Group, celebrating its 360th anniversary in 2025, remains more committed than ever to its purpose "MAKING THE WORLD A BETTER HOME".

 

€46.6 billion in sales in 2024

More than 161,000 employees, locations in 80 countries

Committed to achieving net zero carbon emissions by 2050

 

For more information about Saint-Gobain, visit www.saint-gobain.com and follow us on X @saintgobain

Analyst/investor relations

Press relations

Vivien Dardel:

+33 1 88 54 29 77

Patricia Marie:

+33 1 88 54 26 83

Floriana Michalowska:

+33 1 88 54 19 09

Laure Bencheikh:

+33 1 88 54 26 38

Alix Sicaud:

+33 1 88 54 38 70

Yanice Biyogo: 

 +33 1 88 54 27 96

James Weston: 

+33 1 88 54 01 24

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQRLMFTMTMTBAA
Date   Source Headline
6th Jan 20265:00 pmRNSIntention to delist from the London Stock Exchange
5th Jan 20267:19 amRNSAcquisition
8th Dec 20257:38 amRNSSaint-Gobain cancels 4.2 million shares
1st Dec 20254:58 pmRNSDisposal
30th Oct 20255:54 pmRNS3rd Quarter Results
6th Oct 20257:40 amRNSCapital Markets Day
2nd Oct 20255:10 pmRNSDisposal
1st Oct 20255:08 pmRNSDisposal
26th Sep 20255:14 pmRNSNew plant
8th Sep 20255:12 pmRNSNew construction chemicals organization in Germany
20th Aug 20257:15 amRNSDisposal
31st Jul 20255:51 pmRNSHalf-year Report
29th Jul 20255:10 pmRNSAcquisition
8th Jul 20255:10 pmRNSDisposal
18th Jun 20255:06 pmRNSAcquisition
5th Jun 20256:11 pmRNSNew organization
5th Jun 20255:53 pmRNSAGM Statement
4th Jun 20257:17 amRNSNew plant
20th May 20255:12 pmRNSNew plant
24th Apr 20255:31 pmRNS1st Quarter Results
22nd Apr 20257:00 amRNSSaint-Gobain featured on CDP’s “Climate A List”
26th Mar 20257:00 amRNSBond issue
27th Feb 20255:45 pmRNSAnnual Financial Report
21st Feb 20257:10 amRNSAppointment
10th Feb 20257:12 amRNSAcquisition
4th Feb 20254:54 pmRNSProduction line
16th Jan 20255:41 pmRNSFacility
15th Jan 20255:26 pmRNSAcquisition
3rd Dec 20245:26 pmRNSDecrease in capital
3rd Dec 20247:04 amRNSAcquisition
2nd Dec 20245:10 pmRNSAcquisition
2nd Dec 20247:06 amRNSDisposal
28th Nov 20245:15 pmRNSGovernance
7th Nov 20247:12 amRNSAgreement
29th Oct 20245:55 pmRNS3rd Quarter Results
14th Oct 20245:07 pmRNSAcquisition
8th Oct 20247:05 amRNSAgreement
10th Sep 20245:13 pmRNSDisposal
2nd Sep 20247:06 amRNSDisposal
15th Aug 20246:14 pmRNSAcquisition
31st Jul 20246:07 pmRNSIssue of Debt
26th Jul 20247:00 amRNSHalf-year Report
9th Jul 20247:08 amRNSAcquisition
27th Jun 20247:00 amRNSAcquisition
7th Jun 20247:00 amRNSAGM Statement
3rd Jun 20245:18 pmRNSAcquisition
2nd May 20245:34 pmRNSAgreement
25th Apr 20245:16 pmRNS1st Quarter Results
3rd Apr 20245:44 pmRNSAcquisition
26th Mar 20246:01 pmRNSIssue of Debt

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.